CYP1A1 polymorphisms and lung cancer risk: a meta-analysis. | Pharmacogenetics;10(2): 105-14, 2000 Mar. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

CYP1A1 polymorphisms and lung cancer risk: a meta-analysis.

Houlston, R S.

Affiliation

Houlston RS; Section of Cancer Genetics, Institute of Cancer Research, Sutton, UK. r.houlston@icr.ac.uk

Pharmacogenetics ; 10(2): 105-14, 2000 Mar.

Article in En | MEDLINE | ID: mdl-10761998

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Polymorphism, Genetic / Cytochrome P-450 CYP1A2 / Genetic Predisposition to Disease / Lung Neoplasms Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Pharmacogenetics Year: 2000 Document type: Article Affiliation country:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Polymorphism, Genetic / Cytochrome P-450 CYP1A2 / Genetic Predisposition to Disease / Lung Neoplasms Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Pharmacogenetics Year: 2000 Document type: Article Affiliation country: